PHASE-II ASSESSMENT OF RECOMBINANT LEUKOCYTE-A INTERFERON WITH DIFLUOROMETHYLORNITHINE IN DISSEMINATED MALIGNANT-MELANOMA

被引：10

作者：

CREAGAN, ET ^{[1
]}

LONG, HJ ^{[1
]}

AHMANN, DL ^{[1
]}

SCHAID, DJ ^{[1
]}

机构：

[1] MAYO CLIN & MAYO FDN,CANC CTR STAT,ROCHESTER,MN 55905

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1990年 / 13卷 / 03期

关键词：

D O I：

10.1097/00000421-199006000-00008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Sixteen patients with advanced melanoma received IFN-α2A, 36 x 106 U/m2 i.m., on days 3-7 with 2.25 g/m2 DFMO p.o. on days 1-7. We observed no objective regressions. Median time to progression was 1.2 months with a median survival of 5.2 months. A flu-type syndrome was the predominant sequela. From the dose and schedule that we utilized, this regimen holds little promise against disseminated malignant melanoma.

引用

页码：218 / 220

页数：3

共 12 条

[1] RECOMBINANT INTERFERONS IN THE MANAGEMENT OF ADVANCED MALIGNANT-MELANOMA - UPDATED REVIEW OF 5 PROSPECTIVE CLINICAL-TRIALS AND LONG-TERM RESPONDERS [J].

CREAGAN, ET ;

SCHAID, DJ ;

AHMANN, DL ;

FRYTAK, S .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (06) :652-659

[2]

CREAGAN ET, 1986, CANCER, V58, P2576, DOI 10.1002/1097-0142(19861215)58:12<2576::AID-CNCR2820581203>3.0.CO

[3]

2-6

[4]

EAGAN RT, 1979, CANCER, V44, P1125, DOI 10.1002/1097-0142(197909)44:3<1125::AID-CNCR2820440348>3.0.CO

[5]

2-4

[6] ONE-SAMPLE MULTIPLE TESTING PROCEDURE FOR PHASE-II CLINICAL-TRIALS [J].

FLEMING, TR .

BIOMETRICS, 1982, 38 (01) :143-151

[7] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].

KAPLAN, EL ;

MEIER, P .

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481

[8]

MEYSKENS FL, 1986, INVEST NEW DRUG, V4, P257

[9] A PROGRESS REPORT ON THE TREATMENT OF 157 PATIENTS WITH ADVANCED CANCER USING LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 OR HIGH-DOSE INTERLEUKIN-2 ALONE [J].

ROSENBERG, SA ;

LOTZE, MT ;

MUUL, LM ;

CHANG, AE ;

AVIS, FP ;

LEITMAN, S ;

LINEHAN, WM ;

ROBERTSON, CN ;

LEE, RE ;

RUBIN, JT ;

SEIPP, CA ;

SIMPSON, CG ;

WHITE, DE .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (15) :889-897

[10] USE OF TUMOR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2 IN THE IMMUNOTHERAPY OF PATIENTS WITH METASTATIC MELANOMA - A PRELIMINARY-REPORT [J].

ROSENBERG, SA ;

PACKARD, BS ;

AEBERSOLD, PM ;

SOLOMON, D ;

TOPALIAN, SL ;

TOY, ST ;

SIMON, P ;

LOTZE, MT ;

YANG, JC ;

SEIPP, CA ;

SIMPSON, C ;

CARTER, C ;

BOCK, S ;

SCHWARTZENTRUBER, D ;

WEI, JP ;

WHITE, DE .

NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (25) :1676-1680

← 1 2 →